The evidence framework of traditional Chinese medicine injection (Aidi injection) in controlling malignant pleural effusion: A clustered systematic review and meta-analysis

医学 恶性胸腔积液 胸膜成形术 内科学 荟萃分析 胸腔积液 中医药 随机对照试验 肿瘤科 病理 替代医学
作者
Cheng-Qiong Wang,Jiao Xu,Hong Jiang,Xiao-Tian Zheng,Yan Zhang,Xiao-Rong Huang,Fei She,Teng-Yang Fan,Lin Zhan,Jihong Feng,Qihai Gong,Xue Xiao,Xiaofan Chen,Zheng Xiao
出处
期刊:Phytomedicine [Elsevier]
卷期号:115: 154847-154847 被引量:5
标识
DOI:10.1016/j.phymed.2023.154847
摘要

Aidi injection (Aidi), a traditional Chinese medicine injection, is often practiced to control malignant pleural effusion (MPE). We performed a registered systematic review and meta-analysis (PROSPERO: CRD42022337611) to clarify the clinical role of Aidi in MPE, reveal optimal combinations of Aidi and chemical agents, their indications, therapeutic route and usage, and demonstrate their clinical effectiveness and safety. All randomized controlled trials (RCTs) about Aidi in controlling MPE were collected from Chinese and English databases (up to October 2022). We clustered them into multiple homogenous regimens, evaluated the risk-of-bias at outcome level using a RoB 2, extracted and pooled the data using meta-analysis or descriptive analysis, and finally summarized their evidence quality. All 56 studies were clustered into intrapleural administration with Aidi alone or plus chemical agents, and intravenous administration with Aidi for MPE. Intrapleural administration with Aidi alone displayed similar clinical responses on Cisplatin (DDP) alone. Only administration with Aidi plus DDP significantly improved complete response and quality of life, and displayed a low pleurodesis failure, disease progression, hematotoxicity, gastrointestinal and hepatorenal toxicity. For patients with moderate to massive effusion, Karnofsky Performance Status score ≥ 50 or anticipated survival time ≥3 months, Aidi (50 ml to 80 ml each time, one time each week and three to eight times) plus DDP (20 to 30 mg, 40 to 50 mg, or 60 to 80 mg each time) significantly improved clinical responses. Most results had moderate to low quality. Current evidences indicate that Aidi, a pleurodesis agent, plays an interesting clinical role in controlling MPE. Aidi plus DDP perfusion is a most commonly used regimen, which shows a significant improvement in clinical responses. These findings also provide an indication and possible optimal usage for rational drug use.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Metx完成签到 ,获得积分10
刚刚
1秒前
1秒前
1秒前
wenyue发布了新的文献求助10
1秒前
2秒前
2秒前
小马嘻嘻关注了科研通微信公众号
2秒前
情怀应助高大从雪采纳,获得10
3秒前
3秒前
量子星尘发布了新的文献求助10
3秒前
4秒前
4秒前
动人的莞完成签到,获得积分10
4秒前
4秒前
LZR完成签到,获得积分10
4秒前
Yan0909完成签到,获得积分10
4秒前
沉静白翠发布了新的文献求助10
5秒前
5秒前
6秒前
谦让的博完成签到,获得积分10
6秒前
无花果应助邹秋雨采纳,获得10
6秒前
6秒前
Amyur完成签到,获得积分10
6秒前
wan4221完成签到,获得积分10
7秒前
7秒前
GG发布了新的文献求助10
7秒前
glow完成签到,获得积分10
7秒前
动人的莞发布了新的文献求助100
7秒前
唯有发布了新的文献求助10
8秒前
靴子完成签到,获得积分10
8秒前
完美世界应助Yan0909采纳,获得10
8秒前
脑洞疼应助姬因采纳,获得10
9秒前
打打应助鲤黎黎采纳,获得10
9秒前
我wo发布了新的文献求助10
9秒前
丰富无色完成签到,获得积分10
9秒前
9秒前
cyy发布了新的文献求助10
9秒前
明亮的蝴蝶完成签到,获得积分20
9秒前
程雪霞发布了新的文献求助30
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Basic And Clinical Science Course 2025-2026 3000
Encyclopedia of Agriculture and Food Systems Third Edition 2000
人脑智能与人工智能 1000
花の香りの秘密―遺伝子情報から機能性まで 800
Principles of Plasma Discharges and Materials Processing, 3rd Edition 400
Pharmacology for Chemists: Drug Discovery in Context 400
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5608407
求助须知:如何正确求助?哪些是违规求助? 4693040
关于积分的说明 14876313
捐赠科研通 4717445
什么是DOI,文献DOI怎么找? 2544206
邀请新用户注册赠送积分活动 1509230
关于科研通互助平台的介绍 1472836